TRIALSITEIQ PUBLIC FEASIBILITY SCORECARD · GRADE C

NCT07728253: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trial on the Efficacy and Safety of Probiotic IBNI617 Enteric-Coated Capsules in Patients With Moderate to Severe Depression

Sponsor: IBIOME BIOTECHNOLOGY CO., LTD · Phase: PHASE2 · Area: CNS_NEUROLOGY · Target Enrollment: 148 pts

Competing Trials Overlap

2 Active Trials

Excess Burn Exposure

$12,416,000

Rescue Site Savings

+$8,186,800

Unlock Full NCT07728253 Backup Super-Site Packet ($49 One-Time Pass)

Download the complete list of top-decile low-cannibalization clinical sites, verified Principal Investigator (PI) direct emails/phones, and protocol optimization benchmarks.

Download $49 NCT07728253 Rescue Dossier →